Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice

A SURVEY OF UK PRACTICE
 

Do you perform renal transplants on site YES/NO

If YES how many per year ............................................................................

If NO where are they performed? ....................................................................
 

If YES which hospitals do you devolve long term follow up care to

A. Contact Individual ...................................................................................

Name of Hospital .......................................................................................

Address ...................................................................................................

B. Contact Individual ................................................................................

Name of Hospital .......................................................................................

Address ...................................................................................................

C. Contact Individual ................................................................................

Name of Hospital .......................................................................................

Address ...................................................................................................

Please continue overleaf as required
 

How many long term transplants do you follow up in your Centre (estimate to nearest 20)

Do you have a dedicated transplant clinic YES/NO

If YES how many clinics are there per week ........................................................

How many patients seen per clinic .....................................................................

If NO are transplant patients seen generally in nephrology clinics YES/NO

If NO how and where are they seen ...................................................................

Do you screen renal transplant patients for skin cancer YES/NO

If YES how frequently Annually

(Please ring)

Bi-annually

Other

Who does the skin cancer screening? Nurse led

(Please ring)

Dermatologist

Nephrologist

Other (state)

Has the individual had specific training in recognition of skin cancer?

How is the screening performed?

Full body examination YES/NO

Asking the patient if they have noticed any lesions YES/NO

Other (state) .................................................................................................

Does the screening occur within the regular transplant clinic YES/NO

If NO where ...............................................................................................

Who refers the patient with identified skin lesions: (Please ring)

Nurse Nephrologist Other (state)

Do you educate your patients about skin cancer YES/NO

If YES in what form (Please ring)

Verbal written local or national literature PLEASE SEND EXAMPLES

Do you offer education regarding skin cancer pre-transplant YES/NO

If YES in what form ......................................................................................

What proportion of your population are Caucascian? ..................................................

How is competency assessed? ......................................................................

Do you have onsite dermatology facilities? YES/NO
 

Please state name and contact address of individual completing this questionnaire.

Name ...........................................................................................................

Address .........................................................................................................

.................................................................................................................

.................................................................................................................

Tel/Fax No. ..................................................................................................
 

Thank you for taking the time to complete this questionnaire

Dr. P.N. Harden
Consultant Renal Physician
 

Sarah Reece
Transplant Research Nurse
 

Our Ref: PH/SW
 

22nd November 1999
 

Dear

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

We would be grateful if you would be prepared to complete the enclosed structured questionnaire and return it in the S.A.E. Sarah Reece will also contact you by telephone to provide further information about this project. We are keen to arrange site visits (in early 2000) to Units with existing screening programmes to compare best practical approaches.

We thank you for your interest and support, and are grateful for the time donated to complete the enclosed questionnaire.

Yours sincerely
 

DR. PAUL HARDEN SARAH REECE
CONSULTANT RENAL PHYSICIAN TRANSPLANT RESEARCH NURSE
Enc
 

PROJECT SUPPORTED BY THE LORD TRAFFORD AWARD.
 

Our Ref: PH/SW
 
 

22nd November 1999
 
 

Sister Wilson
Renal Transplant Unit
Aberdeen Royal Infirmary
Foresterhill
ABERDEEN AB25 2ZN
 

Dear Sister Wilson

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

20th January 2000
 

Mrs E Donoghy
Transplant Co-ordinator
Renal Transplant Unit
Belfast City Hospital
Lisburn Road
BELFAST BT9 7TS
 
 

Dear Mrs Elliot

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Birmingham Heartlands
Bordelsey Green East
BIRMINGHAM
B9 5SS

 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Queen Elizabeth Hospital
Edgbaston
BIRMINGHAM
B15 2TH
 
 

Dear Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 

Miss A O'Donnell
Transplant Co-ordinator
Royal Sussex County Hospital
Eastern Road
Brighton BN2 5BE
 
 

Dear Miss O'Donnell

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 

Miss K Draper/Mrs K Hamilton
Renal Transplant Unit
Southmead Hospital
Westbury on Trym
BRISTOL BS10 5NB
 

Dear Miss Draper & Mrs Hamilton

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Transplant Co-ordinator
Renal Transplant Unit
Addenbrooke's Hospital
Hills Road
CAMBRIDGE CB2 2QQ
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Transplant Co-ordinator
Kent & Canterbury Hospital
Ethelburt Road
Canterbury
CT1 3NG
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Mrs C Ho
Transplant Nurse Practitioner
St Helier Hospital
Wrythe Lane
Carshalton
SURREY SM5 1AA
 

Dear Mrs Ho

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 
 

Our Ref: PH/SW

22nd November 1999
 

Mrs E Glynn
Transplant Nurse Practitioner
Renal Transplant Unit
University Hospital of Wales
Heath Park
CARDIFF South Glamorgan
 

Dear Mrs Glynn

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 
Julie 0'Toole
Renal Unit
Walsgrave Hospital
Clifford Bridge Road
COVENTRY CV2 2DX
 

Dear Julie O'Toole

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 
 

Our Ref: PH/SW

22nd November 1999
 
 
Mrs P Cunningham
Transplant Co-ordinator
Renal Transplant Unit
Beaumont Hospital
Dublin 9
REPUBLIC OF IRELAND
 

Dear Mrs Cunningham

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 

Mrs F Jack
Transplant Co-ordinator
Renal Transplant Unit
Ninewells Hospital
Dundee DD1 9SY
 

Dear Mrs Jack

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Mrs J Bradie
Transplant Co-ordinator
Renal Transplant Unit
Edinburgh Royal Infirmary
Lauriston Place
EDINBURGH EH3 9YW
 

Dear Mrs Bradie

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Ms J Phelps
Transplant Co-ordinator
Renal Transplant Unit
Western Infirmary
Dumbarton Road
GLASGOW G11 6NT
 

Dear Ms Phelps

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Mrs J Hadington
Transplant Co-ordinator
Renal Transplant Unit
St James's University Hospital
Beckett Street
LEEDS LS9 7TF
 

Dear Mrs Hadington

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 
Miss R Webb/Miss R Taylor
Transplant Co-ordinator
Renal Transplant Unit
Leicester General Hospital
Gwendolen Road
LEICESTER LE5 4PW
 

Dear Miss Webb & Miss Taylor

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Mrs J Godfrey/Miss E Linacre
Transplant Co-ordinators
Renal Transplant Unit
Royal Liverpool University Hospital
Prescot Street
LIVERPOOL L7 8XP
 

Dear Mrs Godfrey & Miss Linacre

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Transplant Co-ordinator
Renal Transplant Unit
Cromwell Hospital
Cromwell Road
LONDON SW5 0TU
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 

Sister Carleen Kerr
Renal Unit
Guy's Hospital
St Thomas Street
LONDON SE1 9RT
 

Dear Sister Kerr

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Mrs C Brookes/Miss V Dulku
Renal Transplant Nurse Practitioners
2nd Floor Hammersmith House
Hammersmith Hospital
Du Cane Road
LONDON W12 0HS
 

Dear Mrs C Brookes & Miss Dulku

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Transplant Co-ordinator
Renal Transplant Unit
The Harley Street Clinic
35 Weymouth Street
LONDON W1N 4BJ
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Transplant Co-ordinator
Renal Transplant Unit
Kings Healthcare (Dulwich)
East Dulwich Grove
LONDON SE22 8PT
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Transplant Co-ordinator
Renal Transplant Unit
London Bridge Hospital
27 Tooley Street
LONDON SE1 2PR
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Sister Sue Wood
Renal Transplant Office
Atrim Ward
Middlesex Hospital
Mortimer Street
LONDON W1N 8AA
 

Dear Sister Wood

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 

Sister Barbara Suble
Renal Transplant Unit
The Royal Free Hospital
Pond Street
LONDON NW3 2QB
 

Dear Sister Suble

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Co-ordinator
Renal Transplant Unit
The Royal London Hospital
Whitechapel
LONDON E1 1BB
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Sister H Gregson
St George's Hospital
Renal Transplant Unit
Addison Ward
Blackshaw Road
Tooting
LONDON
 

Dear Sister Gregson

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Sister Jane Owen
Renal Outpatients
Mint Wing
St Mary's Hospital
Praed Street
Paddington LONDON W2 1NY
 

Dear Sister Owen

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 

Ms A Valentine
Renal Transplant Nurse Practitioner
Manchester Royal Infirmary
Oxford Road
MANCHESTER M13 9WL
 

Dear Ms Valentine

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Kim Russell
Transplant Co-ordinator
Renal Transplant Unit
Freeman Hospital
Freeman Road
High Heaton
Newcastle upon Tyne NE7 7DN

Dear Ms Russell

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Mr R Bowen/Ms D Cunningham
Renal Transplant Co-ordinator
Renal Transplant Unit
Nottingham City Hospital
Hucknall Road
NOTTINGHAM NG5 1PD
 

Dear Mr Bowen & Ms Cunningham

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW

22nd November 1999
 

Mrs E Holton/Ms S Ward
Renal Transplant Co-ordinators
Renal Unit
Churchill Hospital
Headingten
OXFORD OX3 7LJ
 

Dear Mrs Holton & Ms Ward

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

22nd November 1999
 

Mrs J Spencer
Renal Transplant Practitioners
Renal Transplant Unit
Derriford Hospital
Derriford Road
PLYMOUTH PL6 8DH
 

Dear Mrs Spencer

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

22nd November 1999
 

Mrs A Hansford
Renal Transplant Co-ordinators
Renal Unit
St Mary's Hospital
Milton Road
PORTSMOUTH
Hants P03 6AD
 

Dear Mrs Goodall & Ms Griffiths

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Monklands District General Hospital
Monkscourt Avenue
Airdrie ML6 0JS
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Antrim Hospital
45 Bush Road
Antrim BT41 2RL
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

22nd November 1999
 

Miss A Bentley
Transplant Co-ordinator
Renal Dialysis Unit
Ysbyty Gwynedd
Penrhosgarnedd
Bangor GWYNEDD
LL57 2PW
 

Dear Miss Bentley

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Furness General Hospital
Dalton Lane
Barrow-in-Furness
CUMBRIA LA14 2LT
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Devonshire Road Hospital
Devonshire Road
Blackpool
LANCASHIRE FY3 8AZ
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

22nd November 1999
 

Miss D Oliver
Transplant Nurse
Renal Dialysis Unit
Ysbyty Glan Clwyd Bodelwyddan
Rhyl
CLWYD LL18 5UJ
 

Dear Miss Oliver

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
St Luke's Hospital
Little Morton Lane
Bradford
West Yorks. BD5 0NA
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Cumberland Infirmary
Newtown Road
Carlisle
CUMBRIA CA2 7HY
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
West Wales General Hospital
Carmarthen
Carmarthenshire SA31 2AF
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Broomfield Hospital
Broomfield
CHELMSFORD Essex CM1 5ET
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Cork University Hospital
Wilton
Cork
REPUBLIC OF IRELAND
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Derby City General Hospital
Uttoxeter Road
DERBY DE22 3NE
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Nobles I-O-M Hospital
Douglas
Isle of Man
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Meath Hospital
Heyesbury Street
Dublin 8
Republic of Ireland
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Dumfries & Galloway Royal Infirmary
Bankend Road
Dumfries
DG1 4AP
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Queen Margaret Hospital
Whitefield Road
Dumfermline
KY12 0SU
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Royal Devon & Exeter Hospital (Wonford)
Barrack Road
Exeter
DEVON EX2 5DW
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Uit
Merlin Park Hospital
Galway
Republic of Ireland
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Glasgow Royal Infirmary
Castle Street
Glasgow
G4 0SF
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Stobhill Dialysis Unit
133 Balornock Road
GLASGOW G21 3UW
 

Dear

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Gloucstershire Royal Infirmary
Great Western Road
Gloucester
GL1 3NN
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
James Paget Hospital
Lowestoft Road
Gorkston
GREAT YARMOUTH
NR31 6LA
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

22nd November 1999
 

Mrs B Agus
Transplant Co-ordinator
Renal Dialysis Unit
Hull Royal Infirmary
Royal Hull Hospitals
Anlaby Road
HULL HU3 2JZ
 

Dear Mrs Agus

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Raigmore Hospital
Old Perth Road
Inverness
IV2 3UJ
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Ipswich Hospital
Ipswich
SUFFOLK
IP4 5PD
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Westmorland General Hospital
Burton Road
Kendall
CUMBRIA LA9 7RG
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Crosshouse Hospital
Crosshouse
Kilmarnock
Ayrshire KA2 0BE
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Leeds General Infirmary
Great George Street
LEEDS L51 3EX
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Leicester Royal Infirmary
Infirmary Square
Leicester
LE1 5WW
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Lincoln County Hospital
Greatwell Road
Lincoln
LN2 5QY
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Mossley Hill Hospital
Park Avenue
LIVERPOOL
L18 8BU
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Charing Cross Hospital
116 Fulham Palace Road
LONDON
W6 8RF
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
St Bartholomew's Hospital
(The Royal Hospitals NHS Trust)
West Smithfield
LONDON EC1A 7BE
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
St Thomas' Hospital
Lambeth Palace Roaad
LONDON SE1 7EH
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Withington Hospital
Nell Lane
WEST DIDSBURY
Manchester M20 8LR
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Prince Charles Hospital
Merthyr Tydfil
CF47 9DT
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Royal Victoria Infirmary
Queen Victoria Road
Newcastle Upon Tyne
NE1 4LP
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
St Woolos Hospital
131 Stow Hill
Newport
GWENT NP9 4SZ
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Norfolk & Norwich Hospital
Brunswick Road
Norwich
NR1 3SR
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Tyrone County Hospital
Omagh
County Tyrone
BT79 0AP
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Tranpslant Nurse
Renal Dialysis Unit
John Radcliffe Hospital
Headley Way
Headington
OXFORD OX3 9DU
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
West Norwich Hospital
Bowthorpe Road
Norwich
NORFOLK NR2 3TU
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

22nd November 1999
 

Christine Wroe

Renal Transplant Nurse

Renal Dialysis Unit

Royal Preston Hospital

Sharoe Green Lane North

Fulwood

PRESTON PR2 9HT
 

Dear Christine

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Royal Berkshire Hospital
London Road
Reading
BERKS RG1 5AN
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse

Renal Dialysis Unit
Birch Hill Hospital
Rochdale
LANCASHIRE OL12 9QB
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Rotherham District General Hospital
Moorgate Road
Oakwood
ROTHERHAM
S. Yorks S60 2UD
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
St Albans City Hospital
Waverley Road
St Albans
Herts AL3 5PN
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Hope Hospital
Stott Lane
Salford
LANCASHIRE M6 8HD
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

22nd November 1999
 

Kate Nichols/Gill Owen
Transplant Nurses
Renal Dialysis Unit
The Royal Shrewsbury Hospital
Mytton Oak Road
Shrewsbury SY3 8XQ
 

Dear Ms Nichols & Ms Owen

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

8th November 1999
 

Renal Transplant Nurse

Renal Dialysis Unit

Southampton General Hospital

Iremona Road

Shirley

Southampton

HANTS SO16 6YD
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice
We would like to invite you to participate in a study to determine the sbrrveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Dialysis Unit
Southend Hospital
Prittlewell Chase
Westcliff on Sea
ESSEX SS0 0RY
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.
 

Our Ref: PH/SW
 

8th November 1999
 

Renal Dialysis Unit
Lister Hospital
Corey's Mill Lane
Stevenage
Herts SG1 4AB
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Dialysis Unit
Wordsley Hospital
Wordsley
Stourbridge
WEST MIDLANDS

DY8 5QX
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
City Hospitals Sunderland
Kayll Road
Sunderland SR4 7TP
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
St Anthony's Hospital
London Road
North Cheam
Sutton
SURREY SM3 9DW
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Morriston Hospital NHS Trust
Heor Maes Yr Eglwys
Morriston
SWANSEA SA6 6NL
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Royal Cornwall Hospital (Treliske)
Truro
CORNWALL TF1 3LJ
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Arrowe Park Hospital
Arrowe Park Road
Upton
Wirral
MERSEYSIDE L49 5PE
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

22nd November 1999

Mrs S Moore
Renal Transplant Nurse
Renal Dialysis Unit
New Cross Hospital
Wolverhampton
WV10 0QP
 
 

Dear Mrs Moore

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Maelor General Hospital
Croesnewydd Road
Wrexham
CLWYD LL13 7TD
 
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

8th November 1999
 

Renal Transplant Nurse
Renal Dialysis Unit
Maelor General Hospital
Croesnewyndd Road
Wrexham
CLWYD LL13 7TD
 

Dear Sir/Madam

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.

Our Ref: PH/SW
 

22nd November 1999
 

Mrs S Woolley & Mrs A Oliver
Renal Transplant Nurses
Ward 29
North Staffs. Royal Infirmary
 

Dear Sarah & Annette

Re: Skin Cancer Surveillance Following Renal Transplantation:

A Survey of Current UK Practice

We would like to invite you to participate in a study to determine the surveillance strategies for skin cancer after renal transplantation. In 1998 there were 1612 renal transplants in the UK and there is an existing stock of approximately 15,000 renal transplant recipients in the UK. Skin cancer is one of the most frequent longterm complications; 32% of adult patients transplanted for more than ten years in this Centre have skin cancer. Recently an education and surveillance programme has been established in the Renal Unit at North Staffordshire Hospital, and a cross sectional study of 182 patients with a functioning graft under follow up has been performed. This revealed that 16.5% have skin cancer and 15.4% have actinic keratoses; 39% of the tumours were detected directly as a result of the study and 20% of tumours were on covered body sites.

Last year a limited telephone survey of 25 Transplant Centres in the UK was performed to determine whether regular education and clinical skin surveillance was routinely performed. There was no official policy regarding skin cancer education or surveillance in 56% of the Units. 16% offered verbal or written advice on sun avoidance, fast track or open access referral policy to a Dermatologist was available in a further 12% of Centres which required initial self reporting by the patients. Only 16% of Centres (N=4) had an annual screening programme performed by a Nurse Practitioner or a Dermatologist.

Despite the high incidence of skin cancer amongst transplant recipients in the UK, few Centres offer a structured approach to education or surveillance. The objective of this Survey is to determine current practice with regard to surveillance and patient education for skin cancer in renal transplant patients under longterm care in Renal Units in the UK.